We could not find any results for:
Make sure your spelling is correct or try broadening your search.
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MIR Canada NewsWire VANCOUVER, BC, le 31 août 2023 VANCOUVER, BC, le 31 août...
Canadian Investment Regulatory Organization Trade Resumption - MIR Canada NewsWire VANCOUVER, BC, Aug. 31, 2023 VANCOUVER, BC, Aug. 31, 2023 /CNW/ - Trading resumes in: Company: MedMira...
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Aug. 30, 2023 VANCOUVER, BC, Aug. 30, 2023 /CNW/ - TSX VENTURE COMPANIES LITHIUM ION ENERGY LTD...
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Aug. 29, 2023 VANCOUVER, BC, Aug. 29, 2023 /CNW/ - TSX VENTURE COMPANIES TACTICAL RESOURCES...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MIR Canada NewsWire VANCOUVER, BC, le 29 août 2023 VANCOUVER, BC, le 29 août 2023...
Canadian Investment Regulatory Organization Trading Halt - MIR Canada NewsWire VANCOUVER, BC, Aug. 29, 2023 VANCOUVER, BC, Aug. 29, 2023 /CNW/ - The following issues have been halted by...
HALIFAX, Nova Scotia, July 14, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the appointment of Ms. Pascale Nini to the Board of Directors. In addition, Mr. Thomas...
HALIFAX, Nova Scotia, June 29, 2022 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2022. Profit and Loss...
HALIFAX, Nova Scotia, June 06, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450) for their new innovative and...
HALIFAX, Nova Scotia, May 27, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe and any market accepting the CE mark...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions